产品分类导航
门冬胰岛素  / Insulin Aspart
门冬胰岛素  / Insulin Aspart
门冬胰岛素  / Insulin Aspart

门冬胰岛素 / Insulin Aspart

更新时间:2025-06-18

价格:
CAS号: 116094-23-6
药典: 中国药典,美国药典,欧洲药典
级别: 注射级
立即询盘
收藏

产品详情
下载产品资料

产品名称: 门冬胰岛素 / Insulin Aspart
产品分类: 其他西药原料
CAS号: 116094-23-6
药典: 中国药典,美国药典,欧洲药典
级别: 注射级
产品关键词: 门冬胰岛素,Insulin Aspart
是否为生产商:
主要销售市场: 中国,北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲
是否提供样品:

产品描述:

门冬胰岛素是一种速效人胰岛素类似物,活性类似内源性人胰岛素,其B链28位脯氨酸替换为天冬氨酸后其起效时间大幅缩短至约15分钟,持续时间约3-5小时。可用于治疗1型和2型糖尿病,以改善成人和儿童的血糖控制。

本品由能高效表达门冬胰岛素的大肠杆菌菌株经发酵而来,纯度高,内毒素含量极低,且不含任何动物源性病原体。

Insulin Aspart is a fast-acting human insulin with activity similar to that of endogenous human insulin, and its onset of action is dramatically shortened to about 15 minutes and its duration is about 3-5 hours by substituting aspart amino acids for the pro amino acids at position 28 of the B-chain. It can be used for the treatment of type 1 and type 2 diabetes to improve glycemic control in adults and children.

Virtu Pharmako utilizes E. coli strains to produce insulin aspart. It has extremely low endotoxin content with high purity, and does not contain any animal-derived pathogens.

公司简介

恒敬生物根植于公司核心团队20多年的全球研发积累,创建国际领先的生物制药企业,自创成熟、高效、大规模、成本极具竞争力的生物医药产品,产品涵盖胰岛素类药物、GLP-1类药物以及更多的蛋白类、多肽类产品,位于嘉兴的先进工厂一期设计产能3吨原液和过亿支制剂,二期原液产能超10吨。Virtu Pharmako is a leading biopharmaceutical company with R&D, regulatory submission and CGMP manufacture engaged in four major business areas: Insulin drug portfolio, GLP-1 drug portfolio, biosynthetic technique corporations and varieties of protein/polypeptide bioproducts.With more than 20 years of global R&D study and commercial experiences, the company established the unique, innovative biotechnology platform which efficiently developed dozens of cost-competitive, environment friendly and commercial-scale biomedical products.Our state-of-art, world leading biopharmaceutical manufacture facility with building area 1 Million ft2 is built up in Jiaxing, Zhejiang, China, where located in near Metropolitan City, Shanghai. In Phase I, the production capacity includes 3 metric tonnes per year of API and over 120 million units per year of injectable. Production capacity of Phase II will surpasses 10 metric tonnes of API.
企业规模(人):
业务类型:
成立日期:
年销售额:
主营产品类别:

该公司其他产品

甘精胰岛素  / Insulin Glargine
甘精胰岛素 / Insulin Glargine
门冬胰岛素是一种速效人胰岛素类似物,活性类似内源性人胰岛素,其B链28位脯氨酸替换为天冬氨酸后其起效时间大幅缩短至约15分钟,持续时间约3-5小时。可用于治疗1型和2型糖尿病,以改善成人和儿童的血糖控制。本品由能高效表达门冬胰岛素的大肠杆菌菌株经发酵而来,纯度高,内毒素含量极低,且不含任何动物源性病原体。Insulin Aspart is a fast-acting human insulin with activity similar to that of endogenous human insulin, and its onset of action is dramatically shortened to about 15 minutes and its duration is about 3-5 hours by substituting aspart amino acids for the pro amino acids at position 28 of the B-chain. It can be used for the treatment of type 1 and type 2 diabetes to improve glycemic control in adults and children.Virtu Pharmako utilizes E. coli strains to produce insulin aspart. It has extremely low endotoxin content with high purity, and does not contain any animal-derived pathogens.
德谷胰岛素  / Insulin Degludec
德谷胰岛素 / Insulin Degludec
门冬胰岛素是一种速效人胰岛素类似物,活性类似内源性人胰岛素,其B链28位脯氨酸替换为天冬氨酸后其起效时间大幅缩短至约15分钟,持续时间约3-5小时。可用于治疗1型和2型糖尿病,以改善成人和儿童的血糖控制。本品由能高效表达门冬胰岛素的大肠杆菌菌株经发酵而来,纯度高,内毒素含量极低,且不含任何动物源性病原体。Insulin Aspart is a fast-acting human insulin with activity similar to that of endogenous human insulin, and its onset of action is dramatically shortened to about 15 minutes and its duration is about 3-5 hours by substituting aspart amino acids for the pro amino acids at position 28 of the B-chain. It can be used for the treatment of type 1 and type 2 diabetes to improve glycemic control in adults and children.Virtu Pharmako utilizes E. coli strains to produce insulin aspart. It has extremely low endotoxin content with high purity, and does not contain any animal-derived pathogens.
重组人胰岛素  / Recombinant Human Insulin
重组人胰岛素 / Recombinant Human Insulin
门冬胰岛素是一种速效人胰岛素类似物,活性类似内源性人胰岛素,其B链28位脯氨酸替换为天冬氨酸后其起效时间大幅缩短至约15分钟,持续时间约3-5小时。可用于治疗1型和2型糖尿病,以改善成人和儿童的血糖控制。本品由能高效表达门冬胰岛素的大肠杆菌菌株经发酵而来,纯度高,内毒素含量极低,且不含任何动物源性病原体。Insulin Aspart is a fast-acting human insulin with activity similar to that of endogenous human insulin, and its onset of action is dramatically shortened to about 15 minutes and its duration is about 3-5 hours by substituting aspart amino acids for the pro amino acids at position 28 of the B-chain. It can be used for the treatment of type 1 and type 2 diabetes to improve glycemic control in adults and children.Virtu Pharmako utilizes E. coli strains to produce insulin aspart. It has extremely low endotoxin content with high purity, and does not contain any animal-derived pathogens.
恒敬合创生物医药(浙江)有限公司
注册资本
公司地址
浙江省嘉兴市中国浙江省嘉兴市南湖区大桥镇永叙路368号
联系人
查看联系方式
快速询盘
询盘主题
请输入询盘主题
询盘信息
请输入询盘信息
快速发送询盘
2006-2026 上海博华国际展览有限公司版权所有(保留一切权利) 沪ICP备05034851号-57